Clinical Trial 21980

• Overview

  Study Title:

  Augmented Reality as an Adjunct to Quitline Counseling for Smoking Cessation

  Summary:

  The overall goal of the study is to assess the efficacy of using cue exposure delivered via a smartphone application as an adjunct to Tobacco Quitline treatment to improve smoking abstinence

  Objective:

  Aim 1. Update the existing AR app to be an engaging, user-friendly treatment tool, and verify user satisfaction. Aim 2. Test efficacy of QL+AR over QLO & explore potential moderators and predictors of treatment effects. a. Hypothesis: QL+AR participants will demonstrate higher tobacco abstinence rates six months post enrollment than will QLO participants. b. Potential moderators of interest include sex, nicotine dependence, trait cue reactivity, smoking status during treatment, quitline use, and NRT use. Potential predictors within the QL+AR arm include initial cue reactivity, extinction magnitude and latency, indices of treatment engagement, and AR coach use. Aim 3. Evaluate treatment implementation to guide future quitline adoption, including: a. Cost-assessment and incremental cost-effectiveness analyses comparing QL+AR with QLO. b. Examine treatment engagement and acceptability among those in QL+AR. This will include evaluation of the AR coach. c. Identify facilitators and barriers to incorporating AR treatment into quitline services via qualitative interviews with quitline supervisors, AR coaches, and participants.

• Inclusion Criteria

  • >18 years of age
  • Daily smokers that have quit smoking within the past 3 months (Aim 1) or currently smoking > 3 cigarettes per day for the past year (Aim 2)
  • Functioning telephone number
  • Owns a smart phone capable of supporting AR and willing to download the app
  • Can speak, read and write in English

• Exclusion Criteria

  • Has another household member already enrolled in the study

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.